[en] We have added nine extra residues to the C-terminal of human prolactin and analysed the effect of this mutation on the ability of the hormone to bind to its lactogenic receptor and to induce Nb2 cell division. Both properties are markedly affected when compared to the natural 23-kDa human prolactin. Since no alteration of the global protein folding was detected either by circular dichroism or by infrared spectroscopy, the decrease in biological potency can be exclusively attributed to an effect of the nine additional residues on their near environment. From infrared analysis and secondary structure prediction, the elongated tail is assumed to be involved in a beta-sheet with a few residues initially belonging to the fourth helix. Moreover, from the X-ray structures of porcine and human growth hormones, two proteins homologous to prolactins, the nine extra residues are likely to fold within a concave pocket delimited by helices 1 and 4, and the second half of the loop connecting helices 1 and 2 (loop 1). Thereby, we suggest that the additional residues prevent some residues belonging to this pocket from interacting with the lactogenic receptor. This is in perfect agreement with our earlier proposal that the binding site of prolactin to the lactogenic receptor is homologous to that of growth hormone to the somatogenic receptor, i.e. essentially composed of residues belonging to this concave pocket.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Goffin, Vincent
Struman, Ingrid ; Université de Liège - ULiège > Département des sciences de la vie > Biologie et génétique moléculaire
Goormaghtigh, E.
Martial, Joseph ; Université de Liège - ULiège > Département des sciences de la vie > GIGA-R : Biologie et génétique moléculaire
Language :
English
Title :
The Addition of Nine Residues at the C-Terminus of Human Prolactin Drastically Alters Its Biological Properties
Abdel‐Meguid S.S., Shieh H.S., Smith W.W., Dayringer H.E., Violand B.N., Bentle L.A. (1987) Three‐dimensional structure of a genetically engineered variant of porcine growth hormone. Proceedings of the National Academy of Sciences 84:6434-6437.
Andersen T.T., Ebner K.E. (1979) Reaction of the histidines of prolactin with ethoxyformic anhydride. A binding site modification. J. Biol. Chem. 254:10995-10999.
Bewley T.A., Li C.H. (1972) Circular dichroism studies on human pituitary growth hormone and ovine pituitary lactogenic hormone. Biochemistry 11:884-888.
Biou V., Gibrat J.‐F., Levin J., Robson B., Garnier J. (1988) Secondary structure prediction: combination of the three methods. Protein Eng. 2:185-191.
Boutin J.M., Jolicoeur C., Okamura H., Gagnon J., Edery M., Shirota M., Banville D., Dusanter‐Fourt I., Djiane J., Kelly P.A. (1988) Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family. Cell 53:69-77.
Bradford M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye‐binding. Anal. Biochem. 72:248-254.
Chen Y., Yang J.T., Martinez H.M. (1972) Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispersion. Biochemistry 11:4120-4131.
Chou P., Fasman G. (1978) Prediction of the secondary structure of proteins from their amino acid sequence. Adv. Enzymol. 47:45-148.
Clapp C., Sears P.S., Russell D.H., Richards J., Levay‐Young B.K., Nicoll C.S. (1988) Biological and immunological characterization of cleaved and 16 K forms of rat prolactin. Endocrinology 122:2892-2898.
Clarke W.C., Bern H.A. (1980) Comparative endocrinology of prolactin. Hormonal proteins and peptides , Li, C. H., Academic Press, New York; 8:105-197.
Cooke N.E., Coit D., Shine J., Baxter J., Martial J.A. (1981) Human prolactin: cDNA structural analysis and evolutionary comparisons. J. Biol. Chem. 256:4007-4016.
Cunningham B.C., Jhurani P., Ng P., Wells J.A. (1989) Receptor and antibody epitopes in human growth hormone identified by homolog‐scanning mutagenesis. Science 243:1330-1336.
Cunningham B.C., Wells J.A. (1989) High resolution epitope mapping of hGH‐receptor interactions by alanine‐scanning mutagenesis. Science 244:1081-1084.
Cunnnigham B.C., Ultsch M., de Vos A.M., Mulkerrin M.G., Clauser K.R., Wells J.A. (1991) Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 254:821-825.
Davis J.A., Linzer D.I.H. (1989) A mutant lactogenic hormone that binds, but does not activate, the prolactin receptor. Mol. Endocrinol. 3:949-953.
de la Llosa P., Chene P., Martal J. (1985) Involvement of lysine residues in the binding of ovine prolactin and human growth hormone to lactogenic receptors. FEBS Lett. 191:211-215.
de Vos A.M., Ultsch M., Kossiakoff A.A. (1992) Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255:306-312.
Doonen B.A., Bewley T.A. (1979) Studies on prolactin. Selective reduction of the disulfide bonds of the ovine hormone. Biochemistry 18:4851-4860.
Edery M., Jolicoeur C., Levi‐Meyrueis C., Dusanter‐Fourt I., Petridou B., Boutin J.M., Lesueur L., Kelly P.A. (1989) Identification and sequence analysis of a second form of prolactin receptor by molecular cloning of complementary DNA from rabbit mammary gland. Proc. Natl Acad. Sci. USA 86:2112-2116.
Garnier J., Osguthorpe D., Robson B. (1978) Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J. Mol. Biol. 88:873-894.
Goffin V., Norman M., Martial J.A. (1992) Alanine‐scanning mutagenesis of human prolactin: importance of the 58–74 region for bioactivity. Mol. Endocrinol. 6:1381-1392.
Goormaghtigh E., Cabiaux V., Ruysschaert J.M. (1990) Secondary structure and dosage of soluble and membrane proteins by attenuated total reflection Fourier transform infrared spectroscopy on hydrated films. Eur. J. Biochem. 193:409-420.
Gout P.W., Beer C.T., Noble R.L. (1980) Prolactin‐stimulated growth of cell cultures established from malignant Nb rat lymphomas. Cancer Res. 40:2433-2436.
Kelly P.A., Djiane J., Postel‐Vinay M.‐C., Edery M. (1991) The prolactin/growth hormone receptor family. Endocrine Rev. 12:235-251.
Laemmli U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
Luck D.N., Gout P.W., Beer C.T., Smith M. (1989) Bioactive recombinant methionyl bovine prolactin: structure‐function studies using site‐specific mutagenesis. Mol. Endocrinol. 3:822-831.
Luck D.N., Gout P.W., Kelsay K., Atkinson T., Beer C.T., Smith M. (1990) Recombinant bovine prolactin: loss of bioactivity after single amino acid deletions from putative helical regions. Mol. Endocrinol. 4:1011-1016.
Luck D.N., Huyer M., Gout P.W., Beer C.T., Smith M. (1991) Single amino acid substitutions in recombinant bovine prolactin that markedly reduce its mitogenic activity in Nb2 cell cultures. Mol. Endocrinol. 5:1880-1886.
Miller W.L., Eberhardt N.L. (1983) Structure and evolution of the growth hormone gene family. Endocrine Rev. 4:97-129.
Munson P.J., Rodbard D. (1980) LIGAND: a versatile computerized approach for characterization of ligand‐binding systems. Anal. Biochem. 107:220-239.
Necessary P.C., Andersen T.T., Ebner K.E. (1985) Activity of alkylated prolactin and human growth hormone in receptor and cell assays. Mol. Cell. Endocrinol. 39:247-254.
Nicoll C.S., Bern H.A. (1972) On the action of prolactin among the vertebrates: is there a common denominator? in. Lactogenic hormones , Wolsten‐Holme GEW, Knight, J., eds, pp., Churchill‐Livingston, London; 299-317.
Nicoll C.S., Mayer G.L., Russell S.M. (1986) Structural features of prolactins and growth hormones that can be related to their biological properties. Endocrine Rev. 7:169-203.
Nishikawa S., Nishida Y., Uemura H., Yamada Y., Tanaka T., Uesugi S., Morokawa M., Uchida E., Hayakawa T., Ikehara M. (1989) Structure and activity of artificial mutant variants of human growth hormone. Protein Eng. 3:49-53.
Paris N., Rentier‐Delrue F., Defontaine A., Goffin V., Mercier L., Martial J.A. (1990) Bacterial production and purification of recombinant human prolactin. Biotechnol. Appl. Biochem. 12:436-449.
Salacinski P.R.P., McLean C., Sykes J.E.C., Clement‐Jones V.V., Lowry P. (1981) Iodination of proteins, glycoproteins, and peptides using a solid‐phase oxidizing agent, 1,3,4,6‐tetrachloro‐3α,6α‐diphenyl glycoluril (Iodogen). Anal. Biochem. 117:136-146.
Tanaka T., Shiu R.P.C., Gout P.W., Beer C.T., Noble R.L., Friesen H.G. (1980) A new sensitive and specific bioassay for lactogenic hormones: measurements of prolactin and growth hormone in human serum. J. Clin. Endocrinol. Metab. 51:1058-1063.